These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11600090)

  • 1. Poliomyelitis in Oman. I. The last outbreak?
    Al-Dhahry SH; Koul RL; Al-Busaidy SM; Al-Awaidy ST; Al-Khusaiby SM; Suleman AJ
    Acta Trop; 2001 Oct; 80(2):125-30. PubMed ID: 11600090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.
    Sutter RW; Patriarca PA; Brogan S; Malankar PG; Pallansch MA; Kew OM; Bass AG; Cochi SL; Alexander JP; Hall DB
    Lancet; 1991 Sep; 338(8769):715-20. PubMed ID: 1679866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliomyelitis in Oman. II. Toward eradication.
    Al-Dhahry SH; Al-Awaidy ST; Al-Busaidy SM; Koul RL; Al-Khusaiby SM; Suleman AJ
    Acta Trop; 2001 Oct; 80(2):131-8. PubMed ID: 11600091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.
    Sutter RW; Patriarca PA; Suleiman AJ; Pallansch MA; Zell ER; Malankar PG; Brogan S; al-Ghassani AA; el-Bualy MS
    Int J Epidemiol; 1993 Oct; 22(5):936-44. PubMed ID: 8282476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and control of a poliomyelitis outbreak in Xinjiang, China.
    Luo HM; Zhang Y; Wang XQ; Yu WZ; Wen N; Yan DM; Wang HQ; Wushouer F; Wang HB; Xu AQ; Zheng JS; Li DX; Cui H; Wang JP; Zhu SL; Feng ZJ; Cui FQ; Ning J; Hao LX; Fan CX; Ning GJ; Yu HJ; Wang SW; Liu DW; Wang DY; Fu JP; Gou AL; Zhang GM; Huang GH; Chen YS; Mi SS; Liu YM; Yin DP; Zhu H; Fan XC; Li XL; Ji YX; Li KL; Tang HS; Xu WB; Wang Y; Yang WZ
    N Engl J Med; 2013 Nov; 369(21):1981-90. PubMed ID: 24256377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of paralytic poliomyelitis in Namibia.
    van Niekerk AB; Vries JB; Baard J; Schoub BD; Chezzi C; Blackburn NK
    Lancet; 1994 Sep; 344(8923):661-4. PubMed ID: 7915353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
    Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
    Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
    Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
    PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
    Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
    Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the dynamics of oral poliovirus vaccine cessation.
    Thompson KM; Duintjer Tebbens RJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S475-84. PubMed ID: 25316870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.
    Prevots DR; Ciofi degli Atti ML; Sallabanda A; Diamante E; Aylward RB; Kakariqqi E; Fiore L; Ylli A; van der Avoort H; Sutter RW; Tozzi AE; Panei P; Schinaia N; Genovese D; Oblapenko G; Greco D; Wassilak SG
    Clin Infect Dis; 1998 Feb; 26(2):419-25. PubMed ID: 9502465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio outbreaks in Namibia, 1993-1995: lessons learned.
    Biellik RJ; Allies T; Woodfill CJ; Lobanov A
    J Infect Dis; 1997 Feb; 175 Suppl 1():S30-6. PubMed ID: 9203689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.